Resources

WHO manual on implementing preventative chemotherapy against neglected tropical diseases provides generic tools for those involved in planning preventative chemotherapy administration. The publication was released in September 2022.

New WHO standard operating procedures--released on July 25, 2022--describes the standard operating procedures for health products for NTDs amenable to preventive chemotherapy and the medicines donated to treat them.

This resource document complements the World Health Organization’s (WHO’s) guidance for NTD programs released on July 27, 2020.

The economic impact model and supporting disease-specific tools estimate the direct and indirect economic impact, efficiencies, and societal benefits of investing in NTD programs and interventions. The workshop will explain how NTD programs can use the supporting tools to develop investment cases to advocate for domestic resources and prioritize NTD investments in a multi-disease environment. It will also describe how, with support from HKI and Deloitte, Sierra Leone’s NTD program will pilot these tools and serve as the advisor on country needs, program and financial data, user testing of the tools, and utilization of the outputs for advocacy. After incorporating the feedback from the pilot in Sierra Leone, the Act | West team will make the tools available to all supported countries to create investment cases that enhance advocacy efforts for domestic resource mobilization for NTD programming.

West African neglected tropical diseases (NTD) programs have made great progress toward the elimination/control of NTDs amenable to preventive chemotherapy. However, some districts have failed impact surveys—notably for lymphatic filariasis and trachoma—due to implementation inadequacies, despite reporting good mass treatment coverage. A quality improvement framework has been initiated to strengthen country program interventions and address issues that hinder their ability to achieve the World Health Organization NTD road map elimination/control goals.  The workshop aims to present an innovative model for improving implementation and discuss ideas, strategies, and plans for initiating quality improvement (QI) activities. Experiences from Ghana and Sierra Leone in the design and implementation of the QI model will be shared. 

The gender strategy contains an actionable set of recommendations, based on literature and quantitative and qualitative data, intended to contribute to the overall achievement of Act to End NTDs | West program objectives as well as increased gender equality throughout program implementation.

Dr. Didier Bakajika of the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis presented WHO's guidance for transmission assessment surveys at the USAID lymphatic filariasis transmission assessment survey workshop, hosted by the Act to End NTDs | West and Act to End NTDs | East programs in Abidjan, Cote d'Ivoire on January 15, 2020.

Le Dr Didier Bakajika du Programme mondial d'élimination de la filariose lymphatique de l'Organisation mondiale de la santé a présenté les orientations de l’OMS sur le pre-TAS lors de l'atelier de l'USAID sur les enquêtes d'évaluation de la transmission de la filariose lymphatique, organisé par les programmes Act to End NTDs | West et Act to End NTDs | East à Abidjan, Côte d'Ivoire, le 14 janvier 2020.

Dr. Didier Bakajika of the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis presented WHO's guidance for pre-transmission assessment surveys at the USAID lymphatic filariasis transmission assessment survey workshop, hosted by the Act to End NTDs | West and Act to End NTDs | East programs in Abidjan, Cote d'Ivoire on January 14, 2020.